vs
Side-by-side financial comparison of Eastern Bankshares, Inc. (EBC) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
Eastern Bankshares, Inc. is the larger business by last-quarter revenue ($295.9M vs $208.9M, roughly 1.4× iRhythm Holdings, Inc.). Eastern Bankshares, Inc. runs the higher net margin — 22.1% vs 2.7%, a 19.4% gap on every dollar of revenue. On growth, Eastern Bankshares, Inc. posted the faster year-over-year revenue change (710.6% vs 27.1%). Over the past eight quarters, Eastern Bankshares, Inc.'s revenue compounded faster (38.6% CAGR vs 25.8%).
Eastern Bank is a bank based in Boston, Massachusetts. Before de-mutualizing in 2020, it was the oldest and largest mutual bank in the United States and the largest community bank in Massachusetts.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
EBC vs IRTC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $295.9M | $208.9M |
| Net Profit | $65.3M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | — | 1.1% |
| Net Margin | 22.1% | 2.7% |
| Revenue YoY | 710.6% | 27.1% |
| Net Profit YoY | -34.4% | 518.5% |
| EPS (diluted) | $0.29 | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $295.9M | — | ||
| Q4 25 | $37.5M | $208.9M | ||
| Q3 25 | $241.5M | $192.9M | ||
| Q2 25 | $244.9M | $186.7M | ||
| Q1 25 | $31.1M | $158.7M | ||
| Q4 24 | $216.5M | $164.3M | ||
| Q3 24 | $203.4M | $147.5M | ||
| Q2 24 | $154.0M | $148.0M |
| Q1 26 | $65.3M | — | ||
| Q4 25 | $99.5M | $5.6M | ||
| Q3 25 | $106.1M | $-5.2M | ||
| Q2 25 | $100.2M | $-14.2M | ||
| Q1 25 | $-217.7M | $-30.7M | ||
| Q4 24 | $60.8M | $-1.3M | ||
| Q3 24 | $-6.2M | $-46.2M | ||
| Q2 24 | $26.3M | $-20.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.1% | ||
| Q3 25 | 38.9% | -4.4% | ||
| Q2 25 | 41.0% | -10.0% | ||
| Q1 25 | -590.9% | -20.5% | ||
| Q4 24 | 33.3% | -2.5% | ||
| Q3 24 | -1.6% | -34.1% | ||
| Q2 24 | 24.7% | -15.5% |
| Q1 26 | 22.1% | — | ||
| Q4 25 | 265.6% | 2.7% | ||
| Q3 25 | 44.0% | -2.7% | ||
| Q2 25 | 40.9% | -7.6% | ||
| Q1 25 | -699.2% | -19.3% | ||
| Q4 24 | 28.1% | -0.8% | ||
| Q3 24 | -3.0% | -31.3% | ||
| Q2 24 | 17.1% | -13.6% |
| Q1 26 | $0.29 | — | ||
| Q4 25 | $0.48 | $0.18 | ||
| Q3 25 | $0.53 | $-0.16 | ||
| Q2 25 | $0.50 | $-0.44 | ||
| Q1 25 | $-1.08 | $-0.97 | ||
| Q4 24 | $0.29 | $-0.03 | ||
| Q3 24 | $-0.03 | $-1.48 | ||
| Q2 24 | $0.16 | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $551.7M | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $4.3B | $152.7M |
| Total Assets | $30.6B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $551.7M | — | ||
| Q4 25 | $507.6M | $583.8M | ||
| Q3 25 | $703.4M | $565.2M | ||
| Q2 25 | $948.3M | $545.5M | ||
| Q1 25 | $609.0M | $520.6M | ||
| Q4 24 | $1.9B | $535.6M | ||
| Q3 24 | $1.7B | $522.0M | ||
| Q2 24 | $1.4B | $561.5M |
| Q1 26 | $4.3B | — | ||
| Q4 25 | $4.3B | $152.7M | ||
| Q3 25 | $3.8B | $121.9M | ||
| Q2 25 | $3.7B | $103.7M | ||
| Q1 25 | $3.6B | $86.7M | ||
| Q4 24 | $3.6B | $90.9M | ||
| Q3 24 | $3.7B | $71.8M | ||
| Q2 24 | $3.0B | $99.2M |
| Q1 26 | $30.6B | — | ||
| Q4 25 | $30.6B | $1.0B | ||
| Q3 25 | $25.5B | $995.2M | ||
| Q2 25 | $25.5B | $964.0M | ||
| Q1 25 | $25.0B | $926.1M | ||
| Q4 24 | $25.6B | $931.4M | ||
| Q3 24 | $25.5B | $909.7M | ||
| Q2 24 | $21.0B | $919.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $432.4M | $26.2M | ||
| Q3 25 | $157.1M | $34.9M | ||
| Q2 25 | $123.9M | $27.7M | ||
| Q1 25 | $47.3M | $-7.9M | ||
| Q4 24 | $283.8M | $19.2M | ||
| Q3 24 | $108.3M | $24.3M | ||
| Q2 24 | $54.3M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.35× | 4.70× | ||
| Q3 25 | 1.48× | — | ||
| Q2 25 | 1.24× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.67× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.06× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EBC
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
